2023 is poised to be a banner year for stocks related to stem cell research. The market for stem cell stocks has grown considerably in recent years as biotech companies and healthcare providers alike have sought to harness the power of this life-saving technology. As such, it is no surprise that numerous companies related to stem cell research and its applications will appear on the Nasdaq for the first time in 2023.
As this area of healthcare advances further, healthcare providers and biotechnology firms alike will look to capitalize on and develop potential treatments and cures related to managing and treating illnesses and injuries. Here are some of the biggest Nasdaq stocks related to stem cell research to consider in 2023:
1.Forma Therapeutics – A biotechnology company that focuses on discovering and developing innovative drug-discovery platforms for treating cancer, inflammatory and metabolic diseases.
2. Fate Therapeutics – This company specializes in discovering, creating and manufacturing integrative medicines through cell biology, gene editing, and other novel therapies.
3. Asterias Biotherapeutics – A company that focuses on developing therapies for cancer, heart disease, and neurological conditions utilizing pluripotent stem cells derived from human embryonic or adult sources.
4. Cellular Dynamics International – This company is a leading provider of stem cell technologies and products used in the research, drug discovery process and clinical applications.
5. Accelerate Cell Therapeutics Corporation – A company focused on developing novel cell therapy treatments and products for various neurological conditions including traumatic brain injuries.
6. BioTime Inc – This biotechnology company specializes in utilizing stem cell technology and novel drug delivery systems to treat age-related diseases.
7. Vericel Corporation – This company focuses on regenerative medicine and stem cells and develops treatments for sports medicine, spine degeneration and facial aesthetics.
8. Immunovant – A biopharmaceuticals company focused on the discovery and development of novel therapies for Improved immune responses.
9. Sirenas Therapeutics – This company is focused on stem cell research and harnessing the power of stem cells to treat a variety of illnesses, including neurodegenerative diseases.
10. Insera Therapeutics – A company focused on engineering and manufacturing of biotherapeutic therapies designed for treating diseases.
These ten stocks are the biggest Nasdaq-listed companies related to stem cell research for 2023. As the healthcare industry continues to invest in and develop stem cell treatments, investing in at least some of these stocks could be highly lucrative for investors.
